New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
暂无分享,去创建一个
Roland Eils | Pieter Wesseling | Martin Sill | Volker Hovestadt | Johannes Gojo | Daniela Lötsch | Christine Haberler | Stefan M. Pfister | Brent A. Orr | Paul A. Northcott | Jan Koster | Arie Perry | Matthias Schlesner | Ivo Buchhalter | Stephan Wolf | Amar Gajjar | Felix Sahm | Andrey Korshunov | Nada Jabado | David T. W. Jones | Reinhard Schneppenheim | Alan Mackay | Rogier Versteeg | Silvia Hofer | Stefan Holm | Pascale Varlet | Eleonora Aronica | Chris Jones | Jacques Grill | Jüri Reimand | Matija Snuderl | Christelle Dufour | Christian Mawrin | Marco Prinz | Tom Mikkelsen | Peter Lichter | David W. Ellison | David Scheie | Stefan Rutkowski | David Capper | Andreas von Deimling | Richard Volckmann | Dominik Sturm | Christian Koelsche | Kristian W. Pajtler | Jens Schittenhelm | Till Milde | Felice Giangaspero | Stephan Frank | Anne Jouvet | Catherine Keohane | Christof M. Kramm | Katja von Hoff | Michael C. Frühwald | Torsten Pietsch | Guido Reifenberger | Marina Ryzhova | Matthias A. Karajannis | Ulrich Schüller | Marcel Kool | Christel Herold-Mende | Martin Hasselblatt | Maryam Fouladi | Bret C. Mobley | Walter Berger | Barbara C. Worst | Rainer Grobholz | R. Eils | M. Wolter | G. Reifenberger | T. Mikkelsen | K. Aldape | D. Lötsch | W. Berger | M. Kool | V. Hovestadt | J. Reimand | P. Northcott | M. Schlesner | P. Lichter | S. Pfister | E. Aronica | P. Varlet | A. von Deimling | U. Schüller | P. Wesseling | I. Vajtai | R. Versteeg | S. Hofer | A. Jouvet | M. Snuderl | R. Grobholz | D. Figarella-Branger | D. Ellison | S. Puget | Chris Jones | J. Grill | P. Sluis | V. Hans | K. Pajtler | S. Brabetz | A. Korshunov | D. Capper | A. Deimling | M. Schuhmann | S. Frank | J. Koster | M. Prinz | S. Wolf | M. Sill | C. Kramm | C. Mawrin | A. Mackay | M. Remke | Michael D. Taylor | N. Jabado | S. Dahiya | W. Grajkowska | U. Toprak | T. Pietsch | A. Buccoliero | C. Hagel | A. V. von Bueren | F. Giangaspero | S. Rutkowski | M. Ebinger | B. Worst | I. Buchhalter | P. Johann | G. Balasubramanian | D. Sturm | E. Pfaff | M. Frühwald | K. Hoff | A. Gajjar | M. Hasselblatt | J. Phillips | I. Slavc | D. Scheie | B. Orr | T. Shalaby | M. Grotzer | K. Zitterbart | W. Scheurlen | J. Felsberg | M. Schniederjan | F. Sahm | C. Dufour | M. Karajannis | K. von Hoff | M. Santi | A. Perry | T. Milde | M. Ryzhova | M. Fouladi | C. Koelsche | J. Schittenhelm | C. Haberler | T. Meter | R. Volckmann | T. Van Meter | A. Moore | B. Mobley | R. Drissi | C. Monoranu | R. Schneppenheim | J. Gojo | Marc Remke | Andrew S. Moore | Tarek Shalaby | Michael Grotzer | Karel Zitterbart | Dominique Figarella-Branger | Martin Ebinger | Elke Pfaff | Jörg Felsberg | Wolfram Scheurlen | Kenneth Aldape | Camelia-Maria Monoranu | Maria Łastowska | Marietta Wolter | Christian Hagel | J. Rössler | Joanna J. Phillips | A. Bueren | M. Łastowska | Irene Slavc | Sariah J. Allen | Peter van Sluis | Volkmar Hans | Martin U. Schuhmann | André O. von Bueren | V. Peter Collins | Sonika Dahiya | Stephanie Puget | Umut H. Toprak | David T.W. Jones | Mariarita Santi | Rachid Drissi | Cynthia Cowdrey | Matthew J. Schniederjan | Istvan Vajtai | Sebastian Brabetz | Wiesława Grajkowska | Iris Fried | Irina Leis | Gnanaprakash Balasubramanian | Pascal D. Johann | Diana M. Carvalho | Anna M. Buccoliero | Jochen Rößler | Timothy van Meter | Lynn Ann Forrester | C. Keohane | I. Fried | S. Holm | C. Herold‐Mende | Irina Leis | Cynthia Cowdrey | V. Collins | P. V. van Sluis
[1] M. Roussel,et al. The MN1-TEL Fusion Protein, Encoded by the Translocation (12;22)(p13;q11) in Myeloid Leukemia, Is a Transcription Factor with Transforming Activity , 2000, Molecular and Cellular Biology.
[2] K. Nakai,et al. Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. , 2005, Genome research.
[3] Matthew J. Betts,et al. Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.
[4] Li Ding,et al. C11ORF95-RELA FUSIONS DRIVE ONCOGENIC NF-KB SIGNALING IN EPENDYMOMA. , 2014 .
[5] P. Lichter,et al. TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[7] Jaak Vilo,et al. g:Profiler—a web server for functional interpretation of gene lists (2011 update) , 2011, Nucleic Acids Res..
[8] E. Abu-Isa,et al. High-Grade Undifferentiated Small Round Cell Sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 Fusion: Emerging Entities of Soft Tissue Tumors with Unique Histopathologic Features – A Case Report and Literature Review , 2015, The American journal of case reports.
[9] Gary D Bader,et al. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation , 2010, PloS one.
[10] K. Hansen,et al. Functional normalization of 450k methylation array data improves replication in large cancer studies , 2014, Genome Biology.
[11] R. Siebert,et al. High‐resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors , 2013, Genes, chromosomes & cancer.
[12] T. Jacques,et al. Histologically defined central nervous system primitive neuro-ectodermal tumours (CNS-PNETs) display heterogeneous DNA methylation profiles and show relationships to other paediatric brain tumour types , 2013, Acta Neuropathologica.
[13] R. Siebert,et al. Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. , 2010, American journal of human genetics.
[14] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[15] A. Judkins,et al. Pathology and diagnosis of SMARCB1-deficient tumors. , 2014, Cancer genetics.
[16] Volker Hovestadt,et al. Embryonal tumor with abundant neuropil and true rosettes (ETANTR), ependymoblastoma, and medulloepithelioma share molecular similarity and comprise a single clinicopathological entity , 2013, Acta Neuropathologica.
[17] Pieter Wesseling,et al. International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading , 2014, Brain pathology.
[18] M. Fukuzawa,et al. Consistent in-frame internal tandem duplications of BCOR characterize clear cell sarcoma of the kidney , 2015, Nature Genetics.
[19] Gary D Bader,et al. Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups. , 2015, Cancer cell.
[20] Volker Hovestadt,et al. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays , 2013, Acta Neuropathologica.
[21] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[22] M. Mehta,et al. Outcome and prognostic factors for children with supratentorial primitive neuroectodermal tumors treated with carboplatin during radiotherapy: A report from the Children's Oncology Group , 2015, Pediatric blood & cancer.
[23] Bernat Gel,et al. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and genetic pathways driving tumorigenesis , 2013, Nature Genetics.
[24] Geoffrey E. Hinton,et al. Visualizing Data using t-SNE , 2008 .
[25] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[26] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[27] C. Nordborg,et al. MethPed: a DNA methylation classifier tool for the identification of pediatric brain tumor subtypes , 2015, Clinical Epigenetics.
[28] D. Gisselsson,et al. Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma , 2012, Oncogene.
[29] C. Hsiao,et al. NUT Midline Carcinoma , 2011, International journal of surgical pathology.
[30] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[31] E. Zwarthoff,et al. The MN1-TEL myeloid leukemia-associated fusion protein has a dominant-negative effect on RAR-RXR-mediated transcription , 2007, Oncogene.
[32] Kiran C. Bobba,et al. Discovery of Novel Recurrent Mutations in Childhood Early T-Cell Precursor Acute Lymphoblastic Leukemia by Whole Genome Sequencing - a Report From the St Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project , 2011 .
[33] J. Huse,et al. Evaluation of Histone 3 Lysine 27 Trimethylation (H3K27me3) and Enhancer of Zest 2 (EZH2) in Pediatric Glial and Glioneuronal Tumors Shows Decreased H3K27me3 in H3F3A K27M Mutant Glioblastomas , 2013, Brain pathology.
[34] B. Scheithauer,et al. Focal genomic amplification at 19q13.42 comprises a powerful diagnostic marker for embryonal tumors with ependymoblastic rosettes , 2010, Acta Neuropathologica.
[35] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[36] C. Antonescu,et al. Distinct transcriptional signature and immunoprofile of CIC‐DUX4 fusion–positive round cell tumors compared to EWSR1‐rearranged ewing sarcomas: Further evidence toward distinct pathologic entities , 2014, Genes, chromosomes & cancer.
[37] Sabine Mueller,et al. The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression. , 2013, Genes & development.
[38] Carlos Caldas,et al. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells , 2015, Genome research.
[39] Michael Brudno,et al. Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations , 2014, Nature Genetics.
[40] H. Zentgraf,et al. Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors , 2010, Brain pathology.
[41] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[42] L. Aravind,et al. BEN: a novel domain in chromatin factors and DNA viral proteins , 2008, Bioinform..
[43] L. Rorke,et al. The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. , 1983, Journal of neuropathology and experimental neurology.
[44] Axel Benner,et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[45] D. Brat,et al. Pediatric Neuroblastic Brain Tumors Containing Abundant Neuropil and True Rosettes , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[46] J. Trojanowski,et al. Primitive Neuroectodermal Tumors of the Central Nervous System , 1997, Brain pathology.
[47] V. P. Collins,et al. Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. , 2009, Cancer cell.
[48] Hideo Nakamura,et al. Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. , 2012, The Lancet. Oncology.
[49] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[50] M. Shago,et al. CNS-PNETs with C19MC amplification and/or LIN28 expression comprise a distinct histogenetic diagnostic and therapeutic entity , 2014, Acta Neuropathologica.
[51] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[52] David T. W. Jones,et al. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR) , 2012, Acta Neuropathologica.
[53] F. Kokocinski,et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. , 2004, Cancer research.
[54] Jill P. Mesirov,et al. MEDULLOBLASTOMA EXOME SEQUENCING UNCOVERS SUBTYPE-SPECIFIC SOMATIC MUTATIONS , 2012, Nature.
[55] Li Ding,et al. C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma , 2014, Nature.